Background and Purpose: The enteric neurotransmitter nitric oxide (NO) regulates gastrointestinal motility by relaxing smooth muscle. Pharmacological cAMP induction also relaxes gastrointestinal smooth muscle, but it is uncertain whether cAMP augments or suppresses enteric NO signalling. In other organ systems, cAMP can increase neuronal NO production by stimulating protein kinase A (PKA) to phosphorylate neuronal NOS (nNOS) Serine-1412 (S1412). We hypothesized that cAMP also increases nNOS S1412 phosphorylation by PKA in enteric neurons to augment nitrergic relaxation of mouse ileum.Experimental Approach: We measured contractile force and nNOS S1412 phosphorylation in ileal rings suspended in an organ bath. We used forskolin to induce cAMP-dependent relaxation of wild type, nNOS S1412A knock-in and nNOSα-null ileal rings in the presence or absence of PKA, protein kinase B (Akt) and NOS inhibitors.Key Results: Forskolin stimulated phosphorylation of nNOS S1412 in mouse ileum.Forskolin relaxed nNOSα-null and nNOS S1412A ileal rings less than wild-type ileal rings. PKA inhibition blocked forskolin-induced nNOS phosphorylation and attenuated relaxation of wild type but not nNOS S1412A ileum. Akt inhibition did not alter nNOS phosphorylation with forskolin but did attenuate relaxation of wild type and nNOS S1412A . NOS inhibition with L-NAME eliminated the effects of PKA and Akt inhibitors on relaxation.Conclusion and Implications: PKA phosphorylation of nNOS S1412 augments forskolin-induced nitrergic ileal relaxation. The relationship between cAMP/PKA and NO is therefore synergistic in enteric nitrergic neurons. Because NO regulates gut motility, selective modulation of enteric neuronal cAMP synthesis may be useful for the treatment of gastrointestinal motility disorders. S1412A , mice doubly homozygous for the nNOS S1412A mutation and eNOS knockout; eNOS KO, mice lacking eNOS; eNOS, endothelial NOS; EPAC, exchange factor activated by cAMP; FSK, forskolin; GI, gastrointestinal;-ethyl]-5-isoquinolinesulfonamide HCl; IJP, inhibitory junction potential; KB, Krebs buffer; L-NAME, L-Nitro-L-arginine methyl ester; Myr-PKI, myristoylated PKA inhibitor peptide, residues 14-22; NANTN-[(4S)-4-amino-5-[(2-aminoethyl)-amino]-pentyl]-N 0 -nitroguanidinetris trifluoroacetate; nNOS, neuronal NOS; nNOS S1412A , mice with knock-in mutation of nNOS serine-1412 to alanine; nNOSα KO, mice lacking the first exon of nNOS; ODQ, 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one; pS1412, nNOS phosphorylated at serine-1412; S1179, serine-1179 of mouse eNOS; S1412, serine-1412 of mouse nNOS; sGC, soluble GC; TTX, tetrodotoxin; WT, wild type.